Cross-boundary cancer studies at the University of Tokyo: Oncology in Asian countries: clinical development challenges and opportunities

Jpn J Clin Oncol. 2014 Feb:44 Suppl 1:i54-59. doi: 10.1093/jjco/hyt207.

Author

Pascal Rigaudy¹

Affiliation

¹ please contact Hideyuki Akaza, MD, Department of Strategic Investigation on Comprehensive Cancer Network, Research Center for Advanced Science and Technology, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8904, Japan. akazah@med.rcast.u-tokyo.ac.jp.

PMID: 24516214
DOI: 10.1093/jjco/hyt207

No abstract available

Keywords: cancer in Asia; cancer treatment; cross-boundary cancer studies; drug development; the University of Tokyo.

Publication types

Lecture

MeSH terms

Asia
China
Clinical Trials as Topic / methods
Clinical Trials as Topic / standards
Clinical Trials as Topic / trends
Delivery of Health Care* / organization & administration
Delivery of Health Care* / standards
Delivery of Health Care* / trends
Drug Approval
Drug Industry*
Humans
Incidence
International Cooperation
Japan / epidemiology
Medical Oncology* / organization & administration
Medical Oncology* / standards
Medical Oncology* / trends
Mortality / trends
Neoplasms / drug therapy*
Neoplasms / epidemiology*
Neoplasms / mortality
Republic of Korea
Research Design